Brain scan study shows clot-busting drug benefits stroke patients

April 9, 2015

A drug that breaks up blood clots in the brains of stroke patients could be used more widely than at present without increased risk, a brain scan study suggests.

It had previously been thought that giving the drug to people with signs of early damage in the brain caused by a would increase the chances of them suffering a bleed on the brain - which can be fatal.

The study is the first to show that early tissue damage seen in does not necessarily indicate an increased risk of bleeding. Patients with early tissue damage from strokes are less likely to make a full recovery, but they still benefit from receiving the drug, researchers say.

The drug - called alteplase - is the only treatment for stroke caused by a blocked blood vessel in the brain.

Worries over the appearance of brain scans of taken on arrival at hospital to diagnose strokes have probably meant patients who could have benefitted from alteplase did not receive it, the team says.

Experts were concerned that patients with early - which can be difficult for stroke doctors to see - were more likely to suffer a brain bleed if they were treated with alteplase.

Researchers at the University of Edinburgh found there is only an increased risk of haemorrhage in patients with multiple signs of tissue damage caused by other diseases before the stroke - which are easily identified in scans - together with signs of a fresh clot blocking an artery.

In the small number of people with signs of both previous and a new clot in a blood vessel, 14 per cent of those given alteplase are likely to have a haemorrhage, the team says. However, in people without these signs only three per cent are expected to suffer a bleed if they are given the drug.

Researchers analysed more than 3,000 people involved in a clinical trial assessing the effectiveness of alteplase as a stroke treatment.

Patient risk factors are easy to identify in brain scans, enabling doctors to decide whether the risk to patients outweighs the potential benefits of receiving alteplase, the team says.

The study, published in the journal The Lancet Neurology, was funded by the Medical Research Council.

Professor Joanna Wardlaw, of the University of Edinburgh's Centre for Clinical Brain Sciences, who led the study, said: "Bleeding in the is the main side effect of alteplase, so if we can avoid that hazard, then patients are more likely to benefit. Previous studies have not looked at pre-existing signs of damage nor considered analysing multiple signs in combination, yet having multiple and old signs are both very common in patients with stroke."

Explore further: New drug treatment could offer stroke survivors better outcomes

Related Stories

New drug treatment could offer stroke survivors better outcomes

February 26, 2015
Promising results for a new drug treatment for ischaemic stroke patients have been published today in the journal Lancet Neurology.

Use of anti-clotting drug more than three hours after stroke should be re-evaluated, say researchers

March 17, 2015
Advice to use the anti-clotting drug alteplase more than three hours after an acute stroke should be re-evaluated, say researchers writing in The BMJ this week.

New stroke prevention efforts may be paying off

March 31, 2015
(HealthDay)—Fewer people are being treated in U.S. emergency rooms for strokes caused by blood clots in the brain, which experts read as a sign that current stroke prevention methods are working.

A brighter future after stroke

April 7, 2015
There's a stroke every 10 minutes in Canada. Of those, about 10-15 per cent are triggered by arterial ruptures and uncontrolled bleeding in the brain, and are incredibly devastating. These are the strokes that University ...

Meta-analysis shows that alteplase given promptly after stroke reduces long-term disability

August 6, 2014
Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness, according ...

World's biggest stroke clot-buster trial reveals patient benefits

May 24, 2012
(Medical Xpress) -- Patients given a clot-busting drug within six hours of a stroke are more likely to make a better recovery than those who do not receive the treatment, new research has found.

Recommended for you

Now you like it, now you don't: Brain stimulation can change how much we enjoy and value music

November 20, 2017
Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, ...

Deletion of a stem cell factor promotes TBI recovery in mice

November 20, 2017
UT Southwestern molecular biologists today report the unexpected finding that selectively deleting a stem cell transcription factor in adult mice promotes recovery after traumatic brain injury (TBI).

Brain cell advance brings hope for Creutzfeldt-Jakob disease

November 20, 2017
Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

MRI uncovers brain abnormalities in people with depression and anxiety

November 20, 2017
Researchers using MRI have discovered a common pattern of structural abnormalities in the brains of people with depression and social anxiety, according to a study presented being next week at the annual meeting of the Radiological ...

Neuroscience research provides evidence the brain is strobing, not constant

November 17, 2017
It's not just our eyes that play tricks on us, but our ears. That's the finding of a landmark Australian-Italian collaboration that provides new evidence that oscillations, or 'strobes', are a general feature of human perception.

Brain activity buffers against worsening anxiety

November 17, 2017
Boosting activity in brain areas related to thinking and problem-solving may also buffer against worsening anxiety, suggests a new study by Duke University researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.